Ivermectin’s Cancer Breakthrough: UCLA’s Promising Clinical Trial Dr. McCullough shares details of a groundbreaking UCLA trial exploring ivermectin as a potential anti-cancer therapy. Early results reveal how this decades-old antiparasitic drug may inhibit tumor growth, restore immune function, and reshape how oncology approaches repurposed medications. 👉 Help fund unbiased medical research and protect scientific integrity. ➡️ Donate: mcculloughfnd.org Credit: @RealAmVoice – Just the News, No N

🔥 The truth is — some of the most powerful tools against cancer aren’t new, billion-dollar drugs… they’re old, inexpensive medicines hiding in plain sight. Research shows drugs like ivermectin and mebendazole can disrupt cancer cell pathways, block blood vessel growth, and even target cancer stem cells. Pair them with evidence-backed supplements like Curcumin, Vitamin D, Omega-3s, and Medicinal Mushrooms, and you get a protocol designed to support the body from multiple angles. Comment “PROTOCO

Ivermectin for Cancer: The Latest Breakthroughs You Need to Know New research from UCLA and Cedars-Sinai shows ivermectin may help in treating solid organ cancers. Once dismissed, now it’s entering serious trials—and patients are already adding it to chemo and radiation regimens. 👉 Fund the independent research the system won’t. 👉 Donate today: mcculloughfnd.org Credit: LIVE FROM STUDIO 6B SHOW @lfs6b #MedicalFreedom | McCullough Foundation

19 reactions | Ivermectin isn’t just an anti-parasitic medication....

Ivermectin isn’t just an anti-parasitic medication. It’s being explored for its anti-cancer potential, and here’s what you need to know: 1. Delivery Methods • Oral: Most common, offering systemic absorption. • Transdermal: Applied to the skin for localized effects. • Rectal: Unique pharmacokinetics for specific conditions. • Nebulized: Targets lungs and nasopharynx with low systemic availability. • Intranasal: Safe at 1 mg per nostril for localized action. • Intraperitoneal (IP): In rats, low do